THE IMPACT OF PRENATAL EXPOSURE TO INFECTION ON LATER-LIFE ALCOHOL USE
Washington State University · 01.01.2024
DOI: 10.7273/000007214 ↗Kurz gefasst
Fachartikel in der Zeitschrift Washington State University, erschienen am 01.01.2024. Verfasst von Skylar E. Nicholson.
Abstract (Originalsprache)
Prenatal exposure to infection is a risk factor in the development of several neuropsychiatric disorders, including schizophrenia and depression. These disorders often co-occur with alcohol misuse which leads to adverse outcomes, including increased hospitalization and mortality. Despite these consequences, little is understood regarding the mechanisms regarding how early exposure to infection impacts brain development, which inhibits our ability to create effective therapies. We have previously demonstrated that maternal immune activation (MIA), a model of prenatal exposure to infection, combined with adolescent alcohol exposure (AE) leads to enhanced home-cage drinking and disrupts cortical-striatal oscillations in adult offspring. The current project aims to determine whether these findings extend to operant alcohol self-administration, and whether the anti-oxidant n-acetylcysteine (NAC) may be effective in preventing the effect of MIA on drinking behavior. Pregnant Sprague-Dawley rats were exposed to poly(I:C) (4mg/kg) or saline on gestational day 15 and were exposed to NAC (100 mg/kg) or saline 24 hours before and after MIA treatment. During adolescence, postnatal day (PD) 28-48,
Schlagwörter
Zitieren
APA
Nicholson, S. E. (2024). THE IMPACT OF PRENATAL EXPOSURE TO INFECTION ON LATER-LIFE ALCOHOL USE. Washington State University. https://doi.org/10.7273/000007214
Vancouver
Nicholson SE. THE IMPACT OF PRENATAL EXPOSURE TO INFECTION ON LATER-LIFE ALCOHOL USE. Washington State University. 2024. doi:10.7273/000007214
BibTeX
@article{Nicholson2024,
author = {Nicholson, Skylar E.},
title = {THE IMPACT OF PRENATAL EXPOSURE TO INFECTION ON LATER-LIFE ALCOHOL USE},
journal = {Washington State University},
year = {2024},
doi = {10.7273/000007214}
}
EUVIMED